Literature DB >> 19038073

Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia.

Kurt Christopher Giede1, Tin-Wing Yen2, Rajni Chibbar3, Roger A Pierson1.   

Abstract

OBJECTIVES: Our objectives were (1) to review the rate of concurrent endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia (AEH); (2) to determine the proportion of patients with concurrent endometrial cancer who have high-risk disease; and (3) to re-evaluate our surgical management of AEH.
METHODS: We performed a retrospective chart review of all patients who had surgery on the basis of a preoperative diagnosis of atypical endometrial hyperplasia between January 2001 and December 2006. Demographic data, the method of preoperative diagnosis, postoperative grade of tumour, and other postoperative findings were recorded. When applicable, this included cancer stage, lymph node status, and presence of lymphovascular space invasion. In postoperative review, patients were considered to be high risk if they had disease beyond the uterus or a combination of other risk factors.
RESULTS: Of 70 patients, 25 (35.7%) were found to have concurrent endometrial cancer. This was higher than the commonly accepted rate of 25% (P = 0.03). Of the 25 patients upgraded, 4 (16%) had high-risk cancer on final pathologic evaluation.
CONCLUSION: Simple hysterectomy in women with AEH may result in inadequate surgical management. Simple methods are required to identify patients with a preoperative diagnosis of AEH who may harbour significant cancers.

Entities:  

Mesh:

Year:  2008        PMID: 19038073      PMCID: PMC2891955          DOI: 10.1016/S1701-2163(16)32969-3

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  33 in total

1.  Assessment of depth of myometrial invasion in endometrial adenocarcinoma.

Authors:  B A Goff; L W Rice
Journal:  Gynecol Oncol       Date:  1990-07       Impact factor: 5.482

2.  Clinical value of intraoperative gross examination in endometrial cancer.

Authors:  M Franchi; F Ghezzi; M Melpignano; P L Cherchi; C Scarabelli; C Apolloni; F Zanaboni
Journal:  Gynecol Oncol       Date:  2000-03       Impact factor: 5.482

3.  Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma.

Authors:  E Kucera; C Kainz; A Reinthaller; G Sliutz; S Leodolter; H Kucera; G Breitenecker
Journal:  Gynecol Obstet Invest       Date:  2000       Impact factor: 2.031

4.  Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia.

Authors:  Jamie Shutter; Thomas C Wright
Journal:  Int J Gynecol Pathol       Date:  2005-10       Impact factor: 2.762

5.  GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.

Authors:  Amanda Ashton-Sager; Augusto F G Paulino; Alaa M Afify
Journal:  Appl Immunohistochem Mol Morphol       Date:  2006-06

6.  Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer.

Authors:  C J Dunton; J P Baak; J P Palazzo; P J van Diest; M McHugh; E A Widra
Journal:  Am J Obstet Gynecol       Date:  1996-05       Impact factor: 8.661

7.  Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.

Authors:  M F Janicek; N B Rosenshein
Journal:  Gynecol Oncol       Date:  1994-03       Impact factor: 5.482

8.  The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.

Authors:  R J Kurman; P F Kaminski; H J Norris
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

9.  The accuracy of frozen pathology at time of hysterectomy in patients with complex atypical hyperplasia on preoperative biopsy.

Authors:  Megan D Indermaur; Brenda Shoup; Steve Tebes; Johnathan M Lancaster
Journal:  Am J Obstet Gynecol       Date:  2007-05       Impact factor: 8.661

10.  Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma.

Authors:  J Fanning; Y Tsukada; M S Piver
Journal:  Gynecol Oncol       Date:  1990-04       Impact factor: 5.482

View more
  6 in total

1.  Endometrial Cancer Incidence in Patients With Atypical Endometrial Hyperplasia According to Mode of Management.

Authors:  Anas Barakat; Aemn Ismail; Supratik Chattopadhyay; Quentin Davies
Journal:  Cancer Diagn Progn       Date:  2022-09-03

2.  Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.

Authors:  Theresa Mittermeier; Charlotte Farrant; Michelle R Wise
Journal:  Cochrane Database Syst Rev       Date:  2020-09-06

3.  Endometrial Assessment: When is it Necessary?

Authors:  Juliana Nicoletti Pessoa; Ana Carolina Lopes Freitas; Ronney Antonio Guimaraes; Jonnymar Lima; Helena Lucia Barroso Dos Reis; Antonio Chambo Filho
Journal:  J Clin Med Res       Date:  2013-12-13

4.  Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis.

Authors:  Michelle T Doherty; Omolara B Sanni; Helen G Coleman; Chris R Cardwell; W Glenn McCluggage; Declan Quinn; James Wylie; Úna C McMenamin
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

5.  TWIST1 expression and clinical significance in type I endometrial cancer and premalignant lesions: A retrospective clinical study.

Authors:  Junhua Shen; Qin Chen; Na Li; Xiaoxia Bai; Fenfen Wang; Baohua Li
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

6.  Analysis of endometrial thickness measured by transvaginal ultrasonography in obese patients.

Authors:  Isabela Corrêa Barboza; Daniella de Batista Depes; Ilzo Vianna Júnior; Marisa Teresinha Patriarca; Raquel Martins Arruda; João Alfredo Martins; Reginaldo Guedes Coelho Lopes
Journal:  Einstein (Sao Paulo)       Date:  2014-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.